Abstract
Objectives To investigate whether the effect of chronological age on the risk of developing critical illness in COVID-19 hospitalized individuals is attenuated, and to which extent, when adjusting for increasingly exhaustive measures of the comorbidity burden.
Design Retrospective assessment of electronic health records.
Setting All public hospitals of the Catalan Institute of Health (Catalonia; North-East Spain; 7.7 million inhabitants), which account for 30% of all hospital admissions in Catalonia.
Participants We included all individuals admitted to the hospital with COVID-19 as the main diagnosis between March 1, 2020, and January 31, 2022. Vaccinated individuals and those admitted within the first of the six COVID-19 epidemic waves were excluded from the primary analysis but were included in secondary analyses.
Main outcome measures The primary composite outcome was critical illness, defined as the need for invasive mechanical ventilation, transfer to the intensive care unit (ICU), or in-hospital death (any of them). Explanatory variables included age, sex, and four summary measures of comorbidity burden on admission: the Charlson index (17 diagnostic group codes), the Elixhauser index and count (31 diagnostic group codes), and the Queralt DxS index (3,145 diagnostic group codes). All models were adjusted by wave and center. The proportion of the effect of age attributable to comorbidity burden was assessed using a causal mediation analysis.
Results The primary analysis included 10,090 hospitalizations due to COVID-19; of them, 3,524 experienced a critical illness. The frequency of critical illness increased with age and comorbidity burden on admission, irrespective of the measure used. In multivariate analyses, the effect size of age decreased with the number of diagnoses considered to estimate comorbidity burden. When adjusting for the Queralt DxS index, age showed a minimal contribution to critical illness; according to the causal mediation analysis, comorbidity burden on admission explained the 95.3% (95% CI 82.1% −112.7%) of the observed effect of age on critical illness.
Conclusions When measured exhaustively, comorbidity burden rather than chronological age explains the increased risk of critical illness observed in patients hospitalized with COVID-19.
What is already known on this topic
Age is broadly acknowledged as a critical risk factor for developing critical illness in individuals hospitalized due to COVID-19.
When adjusting for other underlying factors, such as comorbidities, the effect size of age for predicting critical illness decreases; nevertheless, most studies have suggested that age remains independently associated with COVID-19 outcomes.
What this study adds
The observed contribution of chronological age to the risk of critical illness in hospitalized COVID-19 patients decreases with the exhaustivity of the measure of comorbidity burden.
When adjusting for a comprehensive comorbidity index that considers all possible clinical conditions from a weighted list of 3,145 possible diagnostic groups, age has little or no relevant effect on the risk of critical illness.
Mediation analyses confirm that the effect of chronological age on COVID-19 outcomes can be explained by comorbidity burden.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the independent ethics committee of the Bellvitge Biomedical Research Institute (IDIBELL, Spain), which waived obtaining informed consent for the secondary use of data collected during routine care (ref. PR123/22).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
